Examining the mechanisms behind exercise's multifaceted impacts on body composition, cognition, and the gut microbiome in cancer survivors: exploring the links to oxidative stress and inflammation
The promise is real, but clinical readiness is not: Preclinical and early human data are compelling, but without large-scale trials, validated delivery methods, and long-term safety data, Epitalon remains an experimental peptide, one to watch closely, but not yet ready for mainstream clinical adoption
While many peptides show promise in various therapeutic areas, the regulatory process lags due to limited data on safety, efficacy, and standardized manufacturing
Boosts Immunity: Glutathione can boost immunity and help fight against skin diseases like acne and dermatitis
Pathophysiology 23 , 6166 (2016)
After the first developed PARP inhibitor, olaparib, multiple PARP inhibitors such as niraparib, veliparib, and talazoparib were subsequently developed and tested in different phases of clinical trials